PF-05089771
id:
pf-05089771-295-15471274
title:
PF-05089771
text:
PF-05089771 is a selective, small-molecule Nav1.7 and Nav1.8 voltage-gated sodium channel blocker under development by Pfizer as a novel analgesic. As of June 2014, it has completed phase II clinical trials for wisdom tooth removal and primary erythromelalgia.
brand slug:
wiki
category slug:
encyclopedia
description:
Investigational analgesic drug
original url:
https://en.wikipedia.org/wiki/PF-05089771
date created:
date modified:
2024-02-08T14:49:34Z
main entity:
{"identifier":"Q18359206","url":"https://www.wikidata.org/entity/Q18359206"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/b/b9/PF-05089771.svg","width":512,"height":278}
fields total:
13
integrity:
15